YANIMO

This brand name is authorized in Austria, Estonia, Finland, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug YANIMO contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII L64SXO195N - TIOTROPIUM BROMIDE MONOHYDRATE
 

Tiotropium is a long-acting, specific, muscarinic receptor antagonist, in clinical medicine often called an anticholinergic. By binding to the muscarinic receptors in the bronchial smooth musculature, tiotropium inhibits the cholinergic (bronchoconstrictive) effects of acetylcholine, released from parasympathetic nerve endings.

 
Read more about Tiotropium
2
UNII 65R445W3V9 - OLODATEROL HYDROCHLORIDE
 

Olodaterol has a high affinity and high selectivity to the human beta2-adrenoceptor. The compound exerts its pharmacological effects by binding and activation of beta2-adrenoceptors after topical administration by inhalation. Activation of these receptors in the airways results in a stimulation of intracellular adenyl cyclase, an enzyme that mediates the synthesis of cyclic-3',5' adenosine monophosphate (cAMP). Elevated levels of cAMP induce bronchodilation by relaxation of airway smooth muscle cells.

 
Read more about Olodaterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03A Adrenergics, inhalants R Respiratory system → R03 Drugs for obstructive airway diseases
Discover more medicines within R03A
R03AL06 Olodaterol and tiotropium bromide R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1648447, 1648458, 1648469, 1648470
ES Centro de información online de medicamentos de la AEMPS 79966
FI Lääkealan turvallisuus- ja kehittämiskeskus 540404
GB Medicines & Healthcare Products Regulatory Agency 375404
LT Valstybinė vaistų kontrolės tarnyba 1073449, 1077065, 1077066, 1077067
PL Rejestru Produktów Leczniczych 100346066
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W61819001, W61819003, W61819005, W61819006

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.